Physician

James Jacobson Peairs, M.D.

According to 2025 Medicare claims, James Peairs, M.D. (NPI: 1609135623) practices ophthalmology in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is CALIFORNIA RETINA ASSOCIATES, LP (NPI: 1114033404; TIN: 330298426) and primary practice location at 92243-9676.

Peairs' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,698 traditional Medicare patients, billed 9,384 HCPCS/CPT codes, and received $879,271 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 6,293 prescription claims across 1,178 beneficiaries totaling $476,905 in drug costs, led by Cyclosporine (Cyclosporine). Open Payments data shows 28 records totaling $1,792. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $61,889 to $879,271. Similarly, Part D prescription costs have moved sharply higher in recent years, from $10,482 to $476,905. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$440K$879K2016 Medicare payment: $61,889 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $45,226 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $183,479 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $499,279 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $535,634 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $664,578 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $625,370 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $719,711 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $879,271 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20164191,086$61,889
2017398933$45,226
20187962,336$183,479
20191,2405,711$499,279
20201,2125,611$535,634
20211,4626,725$664,578
20221,3816,483$625,370
20231,4857,117$719,711
20241,6989,384$879,271

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$266K$532K2015 Drug cost: $10,482 (USD; Tot_Drug_Cst)2016 Drug cost: $7,213 (USD; Tot_Drug_Cst)2017 Drug cost: $16,880 (USD; Tot_Drug_Cst)2018 Drug cost: $33,984 (USD; Tot_Drug_Cst)2019 Drug cost: $236,600 (USD; Tot_Drug_Cst)2020 Drug cost: $265,230 (USD; Tot_Drug_Cst)2021 Drug cost: $337,893 (USD; Tot_Drug_Cst)2022 Drug cost: $394,208 (USD; Tot_Drug_Cst)2023 Drug cost: $532,175 (USD; Tot_Drug_Cst)2024 Drug cost: $476,905 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152386$10,482
20163487$7,213
201796247$16,880
2018210466$33,984
20195792,780$236,600
20207093,461$265,230
20218294,265$337,893
20228644,411$394,208
20239875,301$532,175
20241,1786,293$476,905

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system1,2811,844$88
92012Established patient problem focused exam of visual system516658$63
92134Imaging of retina1,0141,617$31
92250Photography of the retina836879$27
92133Imaging of optic nerve402406$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CyclosporineCyclosporine1679,330$86,936
LumiganBimatoprost1515,207$50,367
XiidraLifitegrast542,220$49,183
RestasisCyclosporine582,580$48,837
RhopressaNetarsudil Mesylate892,522$27,677

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.28$1,792ANI Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for James Jacobson Peairs, M.D.?

Tedicare shows public-source Medicare data for James Jacobson Peairs, M.D. (NPI 1609135623), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Jacobson Peairs, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Jacobson Peairs, M.D.?

James Jacobson Peairs, M.D. is linked to CALIFORNIA RETINA ASSOCIATES, LP (billing NPI 1114033404) in the available physician profile data.

Does James Jacobson Peairs, M.D. have Open Payments data?

James Jacobson Peairs, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.